Navigation Links
Four Medical Centers Awarded Funds to Improve Outcomes Research for Heart Disease and Stroke
Date:11/5/2008

DALLAS, Nov. 5 /PRNewswire-USNewswire/ -- The American Heart Association and its Pharmaceutical Roundtable have awarded grants totaling $14.5 million for the Outcomes Research Centers initiative. The project will provide a network for cardiovascular and stroke research focusing on the end results, or outcomes, of healthcare for people with or at risk for heart disease and stroke.

The initiative is supported in part by a generous gift from American Heart Association national board member David Spina and his wife, Stevie Spina, of Wayland, Mass.

The award recipients are:

-- Duke University, Durham, N.C. - Center Director: Eric Peterson, M.D.,

M.P.H.

-- Saint Luke's Mid America Heart Institute, Kansas City, Mo. - Center

Director: John Spertus, M.D., M.P.H.

-- Stanford University School of Medicine, Stanford, Calif. - Center

Director: Mark Hlatky, M.D.

-- University of California, Los Angeles, Calif. - Center Director: Barbara

Vickrey, M.D., M.P.H.

It's expected that the interaction among the centers will provide in-depth knowledge and support breakthroughs in outcomes research, while uncovering challenges and successful mechanisms for active collaboration among research centers.

Over the next four years, these four centers will conduct research to determine what interventions, environments, patient factors and other issue most influence improvements in healthcare outcomes for heart disease and stroke patients. Center investigators will meet regularly and share information with each other, as well as provide training for research fellows.

The Outcomes Centers research will explore those interventions and activities that work best and provide the most value in improving healthcare outcomes. The results of the collaborative will ultimately contribute to informed practice and policy decisions by patients, providers, payers and legislators.

These awards are effective Oct. 1, 2008, and will be funded through Sept. 30, 2012.

The American Heart Association Pharmaceutical Roundtable (PRT) is a strategic coalition of ten leading Pharmaceutical companies that support the American Heart Association's mission to build healthier lives, free of cardiovascular diseases and stroke through collective funding of research, patient education, and public and professional programs. Since its inception in 1988, this premier corporate funding group for the National Research Program has committed over $55 million to cardiovascular and stroke research.


'/>"/>
SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract
2. ATS Medical to Participate at the Rodman & Renshaw Annual Global Investment Conference
3. New Vaccines for Adults: Which do you Need? From Harvard Medical School
4. International Medical Corps Continues Delivering Emergency Relief in Democratic Republic of Congo as Potential for Renewed Fighting Threatens to Deepen Crisis
5. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
6. Parker Acquires Medical Gas Delivery Product Line, Expanding Its Dental Equipment Offering
7. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
8. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
9. ATS Medical Announces Third Quarter Results
10. Interview with Dr. Elisabeth Hager, CEO of Balan Biomedical, Inc., to Air Nationally on Sky Radio
11. DRE Medical Equipment Repeats as a Fast 50 Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with First 5 ... services to more than 15,900 children 5 years old and younger and treatment services ... over a span of five years to Western University of Health Sciences, UCLA and ...
(Date:12/2/2016)... Calif. (PRWEB) , ... December 02, 2016 , ... On ... at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who ... neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of travel therapy ... MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason ... extensive financial and operational leadership experience to Advanced Inc. He began his career in ...
(Date:12/2/2016)... ... 02, 2016 , ... The annual time frame to change Medicare health and ... ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current ... need to make changes during this period order for their new policy to go ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... HOUSTON , Dec. 3, 2016   Pairnomix, LLC, ... Precision Medicine Alliance (PEPMA) recognized by the White House, today ... individualized approach to the identification of candidate therapies for a ... SCN8A gene were presented at the 70 th ... in Houston, TX , December 2-6, 2016.  ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the ... SelG1), an anti-P-selectin antibody, reduced the median annual rate ... to placebo (1.63 vs 2.98, p=0.010) in patients with ... that the data are being featured in the official ... of Hematology (ASH) Annual Meeting and presented during the ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 ... evaluating efficacy and safety of CTL019, an investigational ... in relapsed/refractory (r/r) pediatric and young adult patients ... presented today during an oral session at the ... (Abstract #221, December 3, 4:00-5:30 p.m.). The global ...
Breaking Medicine Technology: